Cite

HARVARD Citation

    Barkovskaya, A. et al. (2021). Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen. Molecular oncology. 15 (8), pp. 2026-2045. [Online]. 
  
Back to record